English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Article details
21 September 2017 - ITF BECKER. A new therapeutic approach to the Becker Muscular Dystrophy (BMD)

Paolo Bettica, Vice President R&D ITALFARMACO S.p.A, interviewed for the ITF Becker project

Today, Thursday 21, at 8 pm on CANALE ITALIA (chanel 84 in Italy) during the broadcast “FILO DIRETTO”, dr. Paolo Bettica Vice President R&D ITALFARMACO S.p.A will be interviewed for the ITF Becker project, that project will be conducted in collaboration with OPIS srl (Clinical Research Organization) and Fondazione IRCCS Ca' Granda Maggiore Policlinico Hospital with the Neurology, the Neuromuscular and Rare Diseases and Neuroradiology units; this project is co-financed by Regione Lombardia under the regional operative program 2014-2020 with the aim of “investment in favor of the growing and occupation”.